Beese Fulmer Investment Management Inc. Sells 113 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Beese Fulmer Investment Management Inc. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.9% during the second quarter, HoldingsChannel reports. The fund owned 1,513 shares of the healthcare conglomerate’s stock after selling 113 shares during the quarter. Beese Fulmer Investment Management Inc.’s holdings in UnitedHealth Group were worth $727,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Chelsea Counsel Co. bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $27,000. 25 LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $28,000. Cascade Investment Advisors Inc. acquired a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $28,000. Freedom Wealth Alliance LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $31,000. Finally, Kalos Management Inc. acquired a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $34,000. 85.69% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE UNH opened at $486.06 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $558.10. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.80 and a quick ratio of 0.80. The firm has a market cap of $450.24 billion, a price-to-earnings ratio of 21.75, a PEG ratio of 1.43 and a beta of 0.66. The company has a fifty day moving average price of $492.05 and a 200-day moving average price of $486.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Friday, July 14th. The healthcare conglomerate reported $6.14 earnings per share for the quarter, beating the consensus estimate of $5.92 by $0.22. The company had revenue of $92.90 billion during the quarter, compared to analyst estimates of $90.97 billion. UnitedHealth Group had a net margin of 6.06% and a return on equity of 26.72%. The firm’s revenue for the quarter was up 15.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $5.57 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 24.83 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Monday, September 11th will be given a dividend of $1.88 per share. The ex-dividend date of this dividend is Friday, September 8th. This represents a $7.52 annualized dividend and a yield of 1.55%. UnitedHealth Group’s payout ratio is currently 33.65%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on UNH. Morgan Stanley restated an “overweight” rating and issued a $587.00 price target on shares of UnitedHealth Group in a research report on Friday, July 14th. SVB Securities dropped their target price on shares of UnitedHealth Group from $625.00 to $560.00 in a research report on Wednesday, June 14th. Truist Financial dropped their target price on shares of UnitedHealth Group from $610.00 to $580.00 in a research report on Wednesday, June 14th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of UnitedHealth Group from $564.00 to $555.00 in a research report on Monday, July 17th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Thursday, September 14th. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $575.65.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Andrew Witty sold 4,000 shares of the stock in a transaction dated Wednesday, July 19th. The shares were sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the completion of the transaction, the chief executive officer now owns 78,573 shares in the company, valued at $39,772,866.87. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.